Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lifecore Biomedical Inc 3515 LYMAN BOULEVARD CHASKA MN 55318 USA

www.lifecore.com Employees: 524 P: 952-368-4300

Description:

Lifecore Biomedical Inc. is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. Lifecore Biomedical Inc., formerly known as Landec Corporation, is based in CHASKA, Minn.

Key Statistics

Overview:

Market Capitalization, $K 246,004
Enterprise Value, $K 426,814
Shares Outstanding, K 36,827
Annual Sales, $ 128,260 K
Annual Net Income, $ 12,010 K
Last Quarter Sales, $ 24,710 K
Last Quarter Net Income, $ -16,230 K
EBIT, $ -11,810 K
EBITDA, $ -2,950 K
60-Month Beta 0.94
% of Insider Shareholders 28.21%
% of Institutional Shareholders 83.36%
Float, K 26,438
% Float 71.79%
Short Volume Ratio 0.56

Growth:

1-Year Return -16.88%
3-Year Return -32.56%
5-Year Return -43.06%
5-Year Revenue Growth -77.00%
5-Year Earnings Growth -287.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 10/04/24
Next Earnings Date 08/29/24
Earnings Per Share ttm -0.79
EPS Growth vs. Prev Qtr -253.33%
EPS Growth vs. Prev Year -29.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LFCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -382.65%
Return-on-Assets % -10.21%
Profit Margin % 9.36%
Debt/Equity 3.86
Price/Sales 2.04
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 1.28
Interest Coverage -1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar